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Background
Allergic reactions to CM doses generate controversy
about SOTI treatment. Safety data during maintenance
period of SOTI are limited.
Aim
Describe allergic reactions to CM and trigger factors in
CM anaphylactic patients during maintenance phase of
SOTI (after achieving the maximum tolerated CM dose).
Patients
40 CM anaphylactic children who underwent SOTI to
CM in our Unit between 2006 and 2009.
Methods
Interview with parents. Descriptive data analysis.
Results
Median age: 10.6 years. Median maintenance period: 1.5
years. CM-IgE before SOTI: 101 KU/L. Median thresh-
old dose at oral food challenge before SOTI: 2.5 ml.
Median current daily CM dose: 200 ml.
Allergic reactions to CM: 29 children have had reac-
tions, as follows:
A) Non anaphylactic reactions: 15 children. 8 children
suffer daily from mild symptoms (4, mouth itching; 1,
abdominal pain; 1, hives; 2, rhinitis) and 4 children from
mild asthma 2-3/week, with no triggers associated. 6
children had 1 to 6 mild respiratory or digestive symp-
toms related to trigger factors.
B) 20 children have suffered from anaphylactic reac-
tions, 50% of which are related to trigger factors. 14
patients had skin and respiratory involvement (rank: 65
to 1 episodes). 3 children had skin and digestive symp-
toms (rank: 4 to 1 episodes). 3 children, respiratory
and digestive (rank:13 to 1 episodes). 7 children
received epinephrine (39 doses). Number of children
reacting to CM because of the following trigger factors:
fasting, 5; exercise, 8 (66 episodes); lying, 12 (16 epi-
sodes); tiredness, 3; stress, 3; asthma exacerbation, 4;
infection, 6. 9 children reacted to goat’so rs h e e p ’s
cheese and 4 to cow’s cheese. 7 children have reduced
in 10 to 75% their daily milk doses because of allergic
reactions.
2 children withdrew SOTI during the maintenance
period due to intense and frequent reactions.
Conclusions
Allergic reactions are frequent in CM anaphylactic chil-
dren during maintenance phase of SOTI. Exercise,
asthma, infections, fasting, laying and stress are trigger-
ing factors. Strict follow up and education about allergic
symptoms, triggers, dose reduction and treatment are
crucial to contribute to safety of SOTI.
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